← back to search

Shelley M. Zansky

Texas A&M University · US
Area of research
Epidemiology · Food Science
Research interest
Research focused on Pneumococcal conjugate vaccine and Epidemiology, with related work in Incidence (geometry), Virus, Pneumococcal disease. Notable publications include 'Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based...', 'Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005–2012', and 'Invasive Listeriosis in the Foodborne Diseases Active Surveillance Network (FoodNet), 2004–2009: Further Targeted Prevention Needed for Higher-Risk Groups'.
h-index
citations
3,163
works
23
NIH funding
primary concept
email

Recent publications

Epidemiology of Invasive Group B Streptococcal Infections Among Nonpregnant Adults in the United States, 2008-2016
JAMA Internal Medicine 2019cited by 211position: middledoi
Influenza Vaccination Modifies Disease Severity Among Community-dwelling Adults Hospitalized With Influenza
Clinical Infectious Diseases 2017cited by 185position: middledoi
Social determinants of influenza hospitalization in the United States
Influenza and Other Respiratory Viruses 2017cited by 86position: middledoi
Direct and Indirect Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Invasive Pneumococcal Disease (IPD) Among Children and Adults in the U.S.
Open Forum Infectious Diseases 2017cited by 23position: middledoi
Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005–2012
Clinical Infectious Diseases 2016cited by 408position: middledoi
Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study
The Lancet Respiratory Medicine 2016cited by 197position: middledoi
Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine
Clinical Infectious Diseases 2016cited by 147position: middledoi
Bias with respect to socioeconomic status: A closer look at zip code matching in a pneumococcal vaccine effectiveness study
SSM - Population Health 2016cited by 48position: middledoi
Benefit of Early Initiation of Influenza Antiviral Treatment to Pregnant Women Hospitalized With Laboratory-Confirmed Influenza
The Journal of Infectious Diseases 2016cited by 46position: middledoi
Increased Antiviral Treatment Among Hospitalized Children and Adults With Laboratory-Confirmed Influenza, 2010–2015
Clinical Infectious Diseases 2016cited by 38position: middledoi
Case-Control Study of Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Hospitalizations in Older Adults, United States, 2010–2011
Clinical Infectious Diseases 2016cited by 36position: middledoi
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance
The Lancet Infectious Diseases 2015cited by 725position: middledoi
Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection—United States, 2005–2008
BMC Infectious Diseases 2015cited by 84position: middledoi
Does Influenza Vaccination Modify Influenza Severity? Data on Older Adults Hospitalized With Influenza During the 2012−2013 Season in the United States
The Journal of Infectious Diseases 2015cited by 67position: middledoi
Impact of Prompt Influenza Antiviral Treatment on Extended Care Needs After Influenza Hospitalization Among Community-Dwelling Older Adults
Clinical Infectious Diseases 2015cited by 29position: middledoi
Comparing Clinical Characteristics Between Hospitalized Adults With Laboratory-Confirmed Influenza A and B Virus Infection
Clinical Infectious Diseases 2014cited by 139position: middledoi
Complications Among Adults Hospitalized With Influenza: A Comparison of Seasonal Influenza and the 2009 H1N1 Pandemic
Clinical Infectious Diseases 2014cited by 104position: middledoi
Patients Hospitalized With Laboratory-Confirmed Influenza During the 2010-2011 Influenza Season: Exploring Disease Severity by Virus Type and Subtype
The Journal of Infectious Diseases 2013cited by 124position: middledoi
Complications and Associated Bacterial Coinfections Among Children Hospitalized With Seasonal or Pandemic Influenza, United States, 2003–2010
The Journal of Infectious Diseases 2013cited by 115position: middledoi
Geographic and Temporal Trends in Antimicrobial Nonsusceptibility in Streptococcus pneumoniae in the Post-vaccine era in the United States
The Journal of Infectious Diseases 2013cited by 51position: middledoi
Invasive Listeriosis in the Foodborne Diseases Active Surveillance Network (FoodNet), 2004–2009: Further Targeted Prevention Needed for Higher-Risk Groups
Clinical Infectious Diseases 2012cited by 241position: middledoi
Reduced Influenza Antiviral Treatment Among Children and Adults Hospitalized With Laboratory-Confirmed Influenza Infection in the Year After the 2009 Pandemic
Clinical Infectious Diseases 2012cited by 30position: middledoi
Increase in Rates of Hospitalization Due to Laboratory-Confirmed Influenza Among Children and Adults During the 2009-10 Influenza Pandemic
The Journal of Infectious Diseases 2012cited by 29position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ann Thomas · Oregon Health Authority20 papers (2012–2019)Ruth Lynfield · Minnesota Department of Health18 papers (2012–2019)William Schaffner · Vanderbilt University Medical Center18 papers (2013–2019)Monica M. Farley · Emory University16 papers (2012–2019)Nancy M. Bennett · University of Rochester12 papers (2012–2017)Arthur Reingold · University of California System10 papers (2012–2017) · 9 papers (2013–2017) · 9 papers (2013–2017) · 9 papers (2012–2016)Patricia Ryan · Morgan Stanley Children's Hospital8 papers (2012–2016)James Meek · Yale New Haven Health System8 papers (2013–2016)Lee H. Harrison · Johns Hopkins University8 papers (2013–2019)Lisa A. Miller · University of Iowa7 papers (2015–2017) · 7 papers (2015–2019)Jan Baumbach · Technical University of Munich7 papers (2012–2019)Lyn Finelli · Merck & Co., Inc., Rahway, NJ, USA (United States)6 papers (2013–2016) · 6 papers (2013–2016)Emily Hancock · University of New Mexico6 papers (2012–2015) · 6 papers (2015–2019)Pam Daily Kirley · Minnesota Department of Health5 papers (2013–2017)